Wednesday, June 10, 2026

Intelligence Β· Clinical Development

Pipeline search results

Programs matching β€œAstra” across our ClinicalTrials.gov index β€” phase, modality, sponsor, and trial IDs.

Matching programs 467
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 467 pipeline programs matching "Astra" from NovaPharmaNews Clinical Development Intelligence β€” phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

467 results for β€œAstra” Back to intelligence hub

Search results

Page 20 of 20
  1. AZD1222

    AstraZeneca

    COVID-19, SARS-CoV-2

    approved mab terminated

    1 trial
  2. D3250C00059

    AstraZeneca AB

    Severe eosinophilic asthma

    approved small molecule active

    1 trial
  3. D5980C00048

    AstraZeneca AB

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial
  4. D8223C00016

    AstraZeneca AB

    Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment

    approved small molecule active

    1 trial
  5. D9311L00001

    AstraZeneca

    Advanced or recurrent endometrial cancer

    approved small molecule active

    1 trial
  6. DS-8201a

    AstraZeneca AB

    Treatment of patients with HER2-positive breast cancer with or without brain metastasis

    approved small molecule active

    1 trial
  7. Dapagliflozin

    AstraZeneca

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial
  8. Durvalumab

    AstraZeneca

    Solid Tumor

    approved small molecule completed

    1 trial
  9. RADAR-1 CRPC

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial
  10. Symbicort Turbuhaler (budesonide/formoterol) 320/9 ΞΌg

    AstraZeneca

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule completed

    1 trial
  11. Symbicort Turbuhaler 160/4.5

    AstraZeneca

    Asthma

    approved small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs β€” not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars β€” improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes β€” use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.